Eli Lilly celebrated 150 years, growing from a small Indianapolis lab to a global pharmaceutical giant worth tens of billions ...
The Indianapolis-based drugmaker is marking 150 years since Col. Eli Lilly founded his company on May 10, 1876.
Eli Lilly and Novo Nordisk are building cases for their incretin drugs both new and old as attractive weight loss maintenance ...
In a press release via PR Newswire, Lilly said the initiative launched Tuesday and will support HATCH, United Way Worldwide, ...
By Rishika Sadam May 13 (Reuters) - U.S.-based drugmaker Eli Lilly on Wednesday launched its Alzheimer's drug Lormalzi, also ...
Three pharma CEOs joined the $30 million compensation club in 2025 but Eli Lilly’s David Ricks exceeded his nearest peer by ...
After a stunning Q1 earnings report and raised full-year guidance, the question is whether the valuation has run ahead of ...
FDA Commissioner Marty Makary is resigning, and Kyle Diamantas, the agency's top food regulator, will step in as acting ...
Lilly has a long association with sports, having been a major part of the Tokyo Olympics and last month's hosting of the NCAA ...
Jan 28 (Reuters) - U.S. drugmaker Eli Lilly signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the Germany-based startup said on Wednesday, to develop and commercialize ...
Phase IIIb SURMOUNT-Maintain showed near-complete weight-loss maintenance on maximum tolerated tirzepatide through Week 112, while a 5 mg step-down dose was associated with 5.6 kg mean regain.
Eli Lilly (LLY) on Wednesday rolled out its Alzheimer’s therapy donanemab under the brand name Lormalzi in India, where the percentage of patients affected by the memory-robbing disease is fast rising ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results